EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN FRAIL PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION

被引：1
|
作者：
Coleman, Craig I. [1 ]
Turpie, Alexander [1 ]
Bunz, Thomas J. [1 ]
Sood, Nitesh [1 ]
机构：
[1] Univ Connecticut, Storrs, CT USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1216M-05
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [1] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
    Martinez, Brandon K.
    Sood, Nitesh A.
    Bunz, Thomas J.
    Coleman, Craig I.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [2] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    Bellolio, M. Fernanda
    McBane, Robert D.
    Shah, Nilay D.
    Noseworthy, Peter A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
  • [3] EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS
    Deitelzweig, Steven
    Keshishian, Allison
    Kang, Amiee
    Dhamane, Amol
    Luo, Xuemei
    Li, Xiaoyan
    Balachander, Neeraja
    Rosenblatt, Lisa
    Mardekian, Jack
    Pan, Xianying
    Di Fusco, Manuela
    Garcia, Alessandra Bassalobre
    Yuce, Huseyin
    Lip, Gregory Y. H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 435 - 435
  • [4] Comparative Effectiveness of Dabigatran, Rivaroxaban, Apixaban, and Warfarin in the Management of Patients With Nonvalvular Atrial Fibrillation
    Pink, J.
    Pirmohamed, M.
    Hughes, D. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (02) : 269 - 276
  • [5] Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
    Chan, Yi-Hsin
    See, Lai-Chu
    Tu, Hui-Tzu
    Yeh, Yung-Hsin
    Chang, Shang-Hung
    Wu, Lung-Sheng
    Lee, Hsin-Fu
    Wang, Chun-Li
    Kuo, Chang-Fu
    Kuo, Chi-Tai
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [6] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack
    Coleman, Craig I.
    Peacock, W. Frank
    Bunz, Thomas J.
    Alberts, Mark J.
    [J]. STROKE, 2017, 48 (08) : 2142 - +
  • [7] Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation
    Noseworthy, Peter A.
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    McBane, Robert D.
    Shah, Nilay D.
    [J]. CHEST, 2016, 150 (06) : 1302 - 1312
  • [8] DIRECT COMPARISON OF DABIGATRAN, RIVAROXABAN, AND APIXABAN FOR EFFECTIVENESS AND SAFETY IN NONVALVULAR ATRIAL FIBRILLATION
    Noseworthy, Peter
    Yao, Xiaoxi
    Sangaralingham, Lindsey R.
    Abraham, Neena
    McBane, Robert
    Gersh, Bernard
    Shah, Nilay
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 692 - 692
  • [9] COST-EFFECTIVENESS OF EDOXABAN, APIXABAN, RIVAROXABAN AND DABIGATRAN VERSUS WARFARIN FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
    Marchetti, M.
    Liberato, N. L.
    Rognoni, C.
    Quaglini, S.
    [J]. HAEMATOLOGICA, 2014, 99 : 487 - 487
  • [10] Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation
    Hernandez, Inmaculada
    Zhang, Yuting
    Saba, Samir
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (10): : 1813 - 1819
12345